AGR2-high cells drive a FOXM1-mediated pro-malignancy program in non-functional pancreatic neuroendocrine tumors (NF-PanNETs) and informatively predict patient outcomes

Sci Bull (Beijing). 2026 Jun 6:S2095-9273(26)00629-8. doi: 10.1016/j.scib.2026.06.017. Online ahead of print.
No abstract available